Radiation-Induced Heart Disease: An Under-Recognized Entity?

Cardio-oncology (S Francis, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Cardio-oncology

Opinion statement

Radiation-induced heart disease (RIHD) represents a spectrum of cardiovascular disease in patients who have undergone mediastinal, thoracic, or breast radiotherapy (RT). RIHD may involve any cardiac structure and is a major cause of morbidity and mortality in cancer survivors. While large cohort studies have demonstrated that symptomatic RIHD is a common late finding in this population, the incidence of asymptomatic disease is likely to be even higher. Long-term follow-up with regular screening for RIHD plays an important role in the management of cancer survivors who have undergone RT. Aggressive modification of traditional cardiovascular risk factors such as hypertension, dyslipidemia, and cigarette smoking is essential in patients at risk for RIHD, as these have been shown to potentiate the risks of radiation. In patients with symptomatic RIHD, medical and/or percutaneous therapies are often preferable to surgical interventions in view of the increased surgical risk associated with radiation damage to surrounding tissues. Percutaneous revascularization should generally be favored over surgical revascularization. Transcatheter valve replacements have not been widely used in this population but may offer an alternative to high-risk surgical valve procedures. Pericardiectomy is usually associated with extremely poor short-term and long-term outcomes in patients with RIHD and should be avoided in most cases. Heart transplantation is also higher risk in patients with RIHD than in patients with other etiologies of heart failure, but may be considered in young patients without other comorbidities.


Radiation therapy Radiation-induced heart disease Cardiovascular disease Coronary artery disease Valve disease Restrictive cardiomyopathy Pericardial disease Breast cancer Hodgkin lymphoma 


Compliance with Ethics Guidelines

Conflict of Interest

Dr. Margot Davis and Dr. Ronald M. Witteles each declare no potential conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently as, have been highlighted as: •  Of importance

  1. 1.
    Seemann I et al. Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol. 2012;103:143–50.PubMedCrossRefGoogle Scholar
  2. 2.
    Gabriels K et al. Local heart irradiation of ApoE(-/-) mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis. Radiother Oncol. 2012;105:358–64.PubMedCrossRefGoogle Scholar
  3. 3.
    Halle M, Hall P, Tornvall P. Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B. J Intern Med. 2011;269:469–77.PubMedCrossRefGoogle Scholar
  4. 4.
    Cheng RK et al. Radiation coronary arteritis refractory to surgical and percutaneous revascularization culminating in orthotopic heart transplantation. Cardiovasc Pathol. 2013;22:303–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Taylor CW et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys. 2008;72:501–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Nilsson G et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol. 2012;30:380–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Correa CR et al. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer. J Clin Oncol. 2007;25:3031–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Lind PA et al. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution. Int J Radiat Oncol Biol Phys. 2003;55:914–20.PubMedCrossRefGoogle Scholar
  9. 9.•
    Bouillon K et al. Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol. 2011;57:445–52. One of the major studies establishing the increase in long-term mortality associated with RT for BC. This study was unique in its long duration of follow-up and focus on the contribution of RT to the internal mammary lymph nodes.PubMedCrossRefGoogle Scholar
  10. 10.
    Rademaker J et al. Coronary artery disease after radiation therapy for Hodgkin’s lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. AJR Am J Roentgenol. 2008;191:32–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA. 2003;290:2831–7.PubMedCrossRefGoogle Scholar
  12. 12.
    McEniery PT, Dorosti K, Schiavone WA, Pedrick TJ, Sheldon WC. Clinical and angiographic features of coronary artery disease after chest irradiation. Am J Cardiol. 1987;60:1020–4.PubMedCrossRefGoogle Scholar
  13. 13.
    Hoca A, Yildiz M, Ozyigit G. Evaluation of the effects of mediastinal radiation therapy on autonomic nervous system. Med Oncol. 2012;29:3581–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol. 1996;27:766–73.PubMedCrossRefGoogle Scholar
  15. 15.
    Veeragandham RS, Goldin MD. Surgical management of radiation-induced heart disease. Ann Thorac Surg. 1998;65:1014–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Cohn KE, Stewart JR, Fajardo LF, Hancock EW. Heart disease following radiation. Medicine (Baltimore). 1967;46:281–98.CrossRefGoogle Scholar
  17. 17.
    Carver JR et al. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007;25:3991–4008.PubMedCrossRefGoogle Scholar
  18. 18.
    Chello M et al. Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis. Cardiovasc Surg. 1996;4:222–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I. Diastolic dysfunction after mediastinal irradiation. Am Heart J. 2005;150:977–82.PubMedCrossRefGoogle Scholar
  20. 20.
    Burns RJ et al. Detection of radiation cardiomyopathy by gated radionuclide angiography. AJM. 1983;74:297–302.CrossRefGoogle Scholar
  21. 21.
    Constine LS, Schwartz RG, Savage DE, King V, Muhs A. Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 1997;39:897–906.PubMedCrossRefGoogle Scholar
  22. 22.
    Wethal T et al. Valvular dysfunction and left ventricular changes in Hodgkin’s lymphoma survivors. A longitudinal study. Br J Cancer. 2009;101:575–81.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Carlson RG, Mayfield WR, Normann S, Alexander JA. Radiation-associated valvular disease. Chest. 1991;99:538–45.PubMedCrossRefGoogle Scholar
  24. 24.
    Crestanello JA et al. Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy. Ann Thorac Surg. 2004;78:826–31. discussion 826–31.PubMedCrossRefGoogle Scholar
  25. 25.
    Horimoto M, Igarashi K, Takenaka T, Batra S. Pulmonary infundibular stenosis, coronary artery disease, and aortic regurgitation caused by mediastinal radiation. Am Heart J. 1993;126:1002–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys. 1992;22:887–96.PubMedCrossRefGoogle Scholar
  27. 27.
    Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin’s disease. Cancer. 1992;69:1241–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. JAMA. 1993;270:1949–55.PubMedCrossRefGoogle Scholar
  29. 29.•
    Darby SC et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98. This recent landmark article used a case-control design and estimated cardiac RT doses to demonstrate linear relationship between the risk of CV events and cardiac RT dose in patients treated for BC. It also demonstrated that there was no lower dose threshold for increased risk, thus challenging many widely held beliefs about RIHD.PubMedCrossRefGoogle Scholar
  30. 30.
    Clarke M et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.PubMedCrossRefGoogle Scholar
  31. 31.
    Henson KE, McGale P, Taylor C, Darby SC. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108:179–82.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Eriksson F et al. Long-term cardiac mortality following radiation therapy for Hodgkin’s disease: analysis with the relative seriality model. Radiother Oncol. 2000;55:153–62.PubMedCrossRefGoogle Scholar
  33. 33.
    Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42:743–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Termuhlen AM et al. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011;57:1210–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Mulrooney DA et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Chung E et al. Is there a dose-response relationship for heart disease with low-dose radiation therapy? Int J Radiat Oncol Biol Phys. 2013;85:959–64.PubMedCrossRefGoogle Scholar
  37. 37.
    Vallis KA et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol. 2002;20:1036–42.PubMedCrossRefGoogle Scholar
  38. 38.
    Nixon AJ et al. No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol. 1998;16:1374–9.PubMedGoogle Scholar
  39. 39.
    Kuhnt T et al. Possibility of radiotherapy-associated cardiovascular side effects in breast cancer patients by modern radiotherapy techniques. Breast J. 2007;13:103–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Petersen C, Würschmidt F. Late Toxicity of Radiotherapy: A Problem or a Challenge for the Radiation Oncologist? Breast Care (Basel). 2011;6:369–74.CrossRefGoogle Scholar
  41. 41.
    Carmel RJ. Kaplan, H.S. Mantle irradiation in Hodgkin’s disease. An analysis of technique, tumor eradication, and complications. Cancer. 1976;37:2813–25.PubMedCrossRefGoogle Scholar
  42. 42.
    Højris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet. 1999;354:1425–30.PubMedCrossRefGoogle Scholar
  43. 43.
    Wang W, O’Connell D, Stuart K, Boyages J. Analysis of 10-year cause-specific mortality of patients with breast cancer treated in New South Wales in 1995. J Med Imaging Radiat Oncol. 2011;55:516–25.PubMedCrossRefGoogle Scholar
  44. 44.
    Heidenreich PA et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease. J Clin Oncol. 2007;25:43–9.PubMedCrossRefGoogle Scholar
  45. 45.•
    Lancellotti P et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European association of cardiovascular imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2013;26:1013–32. An excellent summary of the use of various imaging modalities in monitoring and screening for RIHD.PubMedCrossRefGoogle Scholar
  46. 46.
    Curigliano G et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23 Suppl 7:vii155–66.PubMedCrossRefGoogle Scholar
  47. 47.
    Erven K et al. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy. Int J Radiat Oncol Biol Phys. 2013;85:1172–8.PubMedCrossRefGoogle Scholar
  48. 48.
    D’Errico MP et al. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2012;82:e239–46.PubMedCrossRefGoogle Scholar
  49. 49.
    Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013;61:2319–28.PubMedCrossRefGoogle Scholar
  50. 50.
    Erven K et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. Int J Radiat Oncol Biol Phys. 2011;79:1444–51.PubMedCrossRefGoogle Scholar
  51. 51.
    Dogan SM et al. The effect of radiotherapy on cardiac function. Coron Artery Dis. 2012;23:146–54.PubMedCrossRefGoogle Scholar
  52. 52.
    Küpeli S et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin’s lymphoma. J Clin Oncol. 2010;28:1025–30.PubMedCrossRefGoogle Scholar
  53. 53.
    Machann W et al. Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin’s disease. Int J Radiat Oncol Biol Phys. 2011;79:1117–23.PubMedCrossRefGoogle Scholar
  54. 54.
    Hess SL et al. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects. Acta Oncol. 2011;50:653–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Armstrong GT et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013. doi:10.1200/JCO.2013.49.3205.Google Scholar
  56. 56.
    Hoving S, Seemann I, Visser NL, te Poele JA, Stewart FA. Thalidomide is not able to inhibit radiation-induced heart disease. Int J Radiat Biol. 2013;89:685–91.PubMedCrossRefGoogle Scholar
  57. 57.
    Sridharan V et al. Effects of late administration of pentoxifylline and tocotrienols in an image-guided rat model of localized heart irradiation. PLoS ONE. 2013;8:e68762.PubMedCentralPubMedCrossRefGoogle Scholar
  58. 58.
    Swanson T et al. Six-year experience routinely using moderate deep inspiration breath-hold for the reduction of cardiac dose in left-sided breast irradiation for patients with early-stage or locally advanced breast cancer. Am J Clin Oncol. 2013;36:24–30.PubMedCentralPubMedCrossRefGoogle Scholar
  59. 59.
    Hayden AJ, Rains M, Tiver K. Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer. J Med Imaging Radiat Oncol. 2012;56:464–72.PubMedCrossRefGoogle Scholar
  60. 60.
    Reardon KA et al. A comparative analysis of 3D conformal deep inspiratory-breath hold and free-breathing intensity-modulated radiation therapy for left-sided breast cancer. Med Dosim. 2013;38:190–5.PubMedCrossRefGoogle Scholar
  61. 61.
    Formenti SC, DeWyngaert JK, Jozsef G, Goldberg JD. Prone vs supine positioning for breast cancer radiotherapy. JAMA. 2012;308:861–3.PubMedCrossRefGoogle Scholar
  62. 62.
    Maraldo MV et al. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma. Ann Oncol. 2013;24:2113–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Kole TP, Aghayere O, Kwah J, Yorke ED, Goodman KA. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;83:1580–6.PubMedCrossRefGoogle Scholar
  64. 64.
    De Sanctis V et al. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy? Radiat Oncol. 2012;7:129.PubMedCentralPubMedCrossRefGoogle Scholar
  65. 65.
    Hoppe BS et al. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012;84:449–55.PubMedCrossRefGoogle Scholar
  66. 66.
    Witteles RM. Radiation therapy for breast cancer: buyer beware. J Am Coll Cardiol. 2011;57:453–4.PubMedCrossRefGoogle Scholar
  67. 67.
    Goody RB et al. Unintended cardiac irradiation during left-sided breast cancer radiotherapy. Br J Radiol. 2013;86:20120434.PubMedCentralPubMedCrossRefGoogle Scholar
  68. 68.
    Tan W et al. Anterior myocardial territory may replace the heart as organ at risk in intensity-modulated radiotherapy for left-sided breast cancer. Int J Radiat Oncol Biol Phys. 2012;82:1689–97.PubMedCrossRefGoogle Scholar
  69. 69.
    de Almeida CE et al. Potential benefits of using cardiac gated images to reduce the dose to the left anterior descending coronary during radiotherapy of left breast and internal mammary nodes. Cancer Radiother. 2012;16:44–51.PubMedCrossRefGoogle Scholar
  70. 70.
    Vennarini S et al. Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning. Br J Radiol. 2013;86:20120643.PubMedCentralPubMedCrossRefGoogle Scholar
  71. 71.
    Tjessem KH et al. Long-term cardiac mortality after hypofractionated radiation therapy in breast cancer. Int J Radiat Oncol Biol Phys. 2013;87:337–43.PubMedCrossRefGoogle Scholar
  72. 72.
    Whelan TJ et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.PubMedCrossRefGoogle Scholar
  73. 73.
    Stokes EL, Tyldesley S, Woods R, Wai E, Olivotto IA. Effect of nodal irradiation and fraction size on cardiac and cerebrovascular mortality in women with breast cancer treated with local and locoregional radiotherapy. Int J Radiat Oncol Biol Phys. 2011;80:403–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Appelt AL, Vogelius IR, Bentzen SM. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. Clin Oncol (R Coll Radiol). 2013;25(147–152).Google Scholar
  75. 75.
    Epstein AE et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283–352.PubMedCrossRefGoogle Scholar
  76. 76.
    Renner SM, Massel D, Moon BC. Mediastinal irradiation: A risk factor for atherosclerosis of the internal thoracic arteries. Can J Cardiol. 1999;15:597–600.PubMedGoogle Scholar
  77. 77.
    Chang AS et al. Cardiac surgery after mediastinal radiation: extent of exposure influences outcome. J Thorac Cardiovasc Surg. 2007;133:404–13.PubMedCrossRefGoogle Scholar
  78. 78.
    Handa N et al. Coronary artery bypass grafting in patients with previous mediastinal radiation therapy. J Thorac Cardiovasc Surg. 1999;117:1136–42.PubMedCrossRefGoogle Scholar
  79. 79.
    Park CB et al. Identifying patients at particular risk of injury during repeat sternotomy: analysis of 2555 cardiac reoperations. J Thorac Cardiovasc Surg. 2010;140:1028–35.PubMedCrossRefGoogle Scholar
  80. 80.
    van Son JA, Noyez L, van Asten WN. Use of internal mammary artery in myocardial revascularization after mediastinal irradiation. J Thorac Cardiovasc Surg. 1992;104:1539–44.PubMedGoogle Scholar
  81. 81.
    Schulman HE, Korr KS, Myers TJ. Left internal thoracic artery graft occlusion following mediastinal radiation therapy. Chest. 1994;105:1881–2.PubMedCrossRefGoogle Scholar
  82. 82.
    Khan MH, Ettinger SM. Post mediastinal radiation coronary artery disease and its effects on arterial conduits. Catheter Cardiovasc Interv. 2001;52:242–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Siregar S, de Heer F, van Herwerden LA. Cardiac surgery in patients irradiated for Hodgkin’s lymphoma. Neth Heart J. 2010;18:61–5.PubMedCentralPubMedCrossRefGoogle Scholar
  84. 84.
    Brown ML, Schaff HV, Sundt TM. Conduit choice for coronary artery bypass grafting after mediastinal radiation. J Thorac Cardiovasc Surg. 2008;136:1167–71.PubMedCrossRefGoogle Scholar
  85. 85.•
    Wu W et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation. 2013;127:1476–85. This is one of the largest studies of outcomes after cardiac surgery in patients with RIHD, providing important evidence of the increased risk associated with surgical procedures in this population.PubMedCrossRefGoogle Scholar
  86. 86.
    Schömig K et al. Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement. Catheter Cardiovasc Interv. 2007;70:359–65.PubMedCrossRefGoogle Scholar
  87. 87.
    Dubois CL et al. Clinical outcome of coronary stenting after thoracic radiotherapy: a case-control study. Heart. 2010;96:678–82.PubMedCrossRefGoogle Scholar
  88. 88.
    Leon MB et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.PubMedCrossRefGoogle Scholar
  89. 89.
    Smith CR et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.PubMedCrossRefGoogle Scholar
  90. 90.
    Latib A et al. Percutaneous valve replacement in a young adult for radiation-induced aortic stenosis. J Cardiovasc Med (Hagerstown). 2012;13:397–8.CrossRefGoogle Scholar
  91. 91.
    Handa N et al. Valvular heart operation in patients with previous mediastinal radiation therapy. Ann Thorac Surg. 2001;71:1880–4.PubMedCrossRefGoogle Scholar
  92. 92.
    Ling LH et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100:1380–6.PubMedCrossRefGoogle Scholar
  93. 93.
    Handa N et al. Heart transplantation for radiation-associated end-stage heart failure. Transpl Int. 2000;13:162–5.PubMedCrossRefGoogle Scholar
  94. 94.
    DePasquale EC, Nasir K, Jacoby DL. Outcomes of adults with restrictive cardiomyopathy after heart transplantation. J Heart Lung Transplant. 2012;31:1269–75.PubMedCrossRefGoogle Scholar
  95. 95.
    Nohria A. Should we avoid heart transplantation in cardiomyopathy due to radiotherapy/chemotherapy or amyloidosis? The devil is in the details. J Heart Lung Transplant. 2012;31:1253–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Division of Cardiovascular MedicineStanford University School of MedicineStanfordUSA

Personalised recommendations